secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARKO Corp. (ARKO)
CIK:        0001823794
Form:       8-K
Filed at:   2023-06-02T23:59:59+00:00
Accession:  0000950170-23-026140
Event type: regulatory
Sentiment:  negative
Materiality: 0.45
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

ARKO non-compliant with Nasdaq audit committee rule after director resignation; cure period until Nov 1, 2023
--------------------------------------------------------------------------------

- Director Starlette Johnson resigned from board and audit committee effective May 5, 2023.
- Audit Committee now has fewer than three members, violating Nasdaq Listing Rule 5605(c)(2).
- Nasdaq confirmed non-compliance on June 2, 2023; cure period expires November 1, 2023.
- Company expects to cure before deadline and actively seeking audit committee replacement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1823794/000095017023026140/0000950170-23-026140-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1823794/000095017023026140/arko-20230531.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-026140

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer